CYP3A4*22 Genotyping Test: Personalized Medication Response Analysis
Understanding CYP3A4*22 Genotyping
The CYP3A4*22 Genotyping Test represents a breakthrough in personalized medicine, offering profound insights into how your body processes medications. This advanced genetic analysis focuses on the CYP3A4 enzyme, one of the most important drug-metabolizing enzymes in the human body, responsible for processing approximately 50% of all prescription drugs currently available.
What Does the CYP3A4*22 Genotyping Test Measure?
This sophisticated genetic test specifically detects the presence of the CYP3A4*22 allele, a crucial genetic variant that significantly impacts enzyme activity. The test examines:
- Presence or absence of the CYP3A4*22 genetic variant
- Genetic predisposition for altered drug metabolism
- Individual metabolic capacity for CYP3A4 substrates
- Potential for medication toxicity or reduced efficacy
Who Should Consider CYP3A4*22 Genotyping?
This test is particularly beneficial for individuals experiencing:
- Unexpected medication side effects or adverse reactions
- Poor response to standard medication dosages
- History of medication toxicity despite normal dosing
- Planned treatment with medications metabolized by CYP3A4
- Complex medication regimens requiring optimization
- Chronic conditions requiring long-term pharmaceutical management
Clinical Applications and Benefits
The CYP3A4*22 Genotyping Test provides numerous advantages for patient care:
- Personalized Dosing: Enables tailored medication dosages based on individual metabolic capacity
- Enhanced Safety: Reduces risk of adverse drug reactions and toxicity
- Improved Efficacy: Optimizes therapeutic outcomes through genetic-guided prescribing
- Cost-Effective Care: Prevents medication trial-and-error approaches
- Comprehensive Insights: Provides lifelong genetic information for future medication decisions
Understanding Your Test Results
Your CYP3A4*22 genotyping results will fall into one of several categories:
Normal Metabolizer
Individuals without the CYP3A4*22 variant typically process medications at standard rates and may respond well to conventional dosing strategies.
Intermediate Metabolizer
Heterozygous carriers of the CYP3A4*22 allele may experience moderately reduced enzyme activity, potentially requiring dosage adjustments for certain medications.
Poor Metabolizer
Individuals homozygous for the CYP3A4*22 variant demonstrate significantly reduced enzyme activity, often necessitating substantial dosage modifications or alternative medication selection.
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | CYP3A4*22 Genotyping Test |
| Discount Price | $226 USD |
| Regular Price | $376 USD |
| Turnaround Time | Sample Sat by 11 am; Report 10 Working Days |
| Sample Type | 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube |
| Shipping Requirements | Ship refrigerated. DO NOT FREEZE |
| Required Documentation | Duly filled Genomics Clinical Information Requisition Form (Form 20) |
| Testing Method | PCR, Sequencing |
| Department | Molecular Diagnostics |
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities. Our extensive network ensures accessible, high-quality genetic testing services nationwide.
Take Control of Your Medication Journey
Don’t leave your medication response to chance. The CYP3A4*22 Genotyping Test provides scientifically validated insights that can transform your treatment experience. Whether you’re starting new medications, managing chronic conditions, or seeking to optimize current therapies, this test offers invaluable information for your healthcare team.
Ready to Schedule Your Test?
Take the first step toward personalized medication management. Our dedicated team is available to answer your questions and schedule your appointment. Call us today at +1(267) 388-9828 or book your CYP3A4*22 Genotyping Test online to unlock the power of genetic-guided prescribing.
Disclaimer: This test should be interpreted by qualified healthcare professionals in conjunction with clinical assessment and other relevant medical information. Genetic testing results are one component of comprehensive medical decision-making.
